EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Nephronophthisis: Current clinical spectrum and molecular pathogenesis

Ya Li iD, Siwei Yang iD, Xiying Chen iD, Jianhua Mao iD, Shanshan Xie iD

The FEBS Journal · 04.07.2026

DOI: 10.1111/febs.70646 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The FEBS Journal, online erschienen am 04.07.2026. Verfasst von Ya Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Children and Adolescents' Health and Diseases, Han…. Hauptthemen laut MEDLINE: Kidney Diseases, Cystic, Kidney Failure, Chronic. Die Arbeit nennt 62 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Noncommunicable Chronic Diseases-National Science and Technology Major Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nephronophthisis (NPH) is a ciliopathy primarily affecting renal tubules and interstitial tissue, ultimately progressing to end‐stage kidney disease (ESKD). The clinical spectrum of NPH is broad and can be classified according to the age at onset into infantile, juvenile, adolescent, and late‐onset forms. Histopathologically, NPH is characterized by corticomedullary cysts, tubular atrophy, interstitial fibrosis, and cystic dilatation of distal tubules. The kidneys may appear normal in early stages but gradually shrink with disease progression. More than 20 causative genes have been identified, with NPHP1 being the most common. These genes encode proteins that localize predominantly to the ciliary transition zone and basal body, where they regulate ciliary structure and signaling. Loss of ciliary function disrupts epithelial polarity, intracellular trafficking, and signal transduction, leading to tubular injury and fibrosis. When extrarenal organs such as the retina, liver, or central nervous system are affected, the condition is defined as nephronophthisis‐related ciliopathies (NPH‐RC). This review summarizes the current understanding of NPH classification, clinical features, and molecular mechanisms. Here, we highlighted recent advances in genetic discoveries, pathogenic signaling pathways, and therapeutic strategies, including gene therapy and targeted molecular interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney Diseases, CysticKidney Failure, ChronicHumansCiliaAdaptor Proteins, Signal TransducingAnimalsSignal TransductionMutationMembrane ProteinsCytoskeletal Proteins

Stichwörter der Autor:innen

CiliopathyGenetic pathogenesisKidney diseaseNephronophthisisPrimary cilia

Substanzen

NPHP1 protein, humanAdaptor Proteins, Signal TransducingMembrane ProteinsCytoskeletal Proteins

Autor:innen und Institutionen

  • Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Children and Adolescents' Health and Diseases, Hangzhou, China.
  • Department of Cell Biology, Zhejiang University School of Medicine, Hangzhou, China.
  • Kidney Disease Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

ORCID-Profile: Ya Li, Siwei Yang, Xiying Chen, Jianhua Mao, Shanshan Xie

Förderung

  • National Natural Science Foundation of China
  • Noncommunicable Chronic Diseases-National Science and Technology Major Project

Zitieren

APA

Li, Y., Yang, S., Chen, X., Mao, J., & Xie, S. (2026). Nephronophthisis: Current clinical spectrum and molecular pathogenesis. The FEBS Journal. https://doi.org/10.1111/febs.70646

Vancouver

Li Y, Yang S, Chen X, Mao J, Xie S. Nephronophthisis: Current clinical spectrum and molecular pathogenesis. The FEBS Journal. 2026. doi:10.1111/febs.70646

BibTeX
@article{Li2026,
  author = {Li, Ya and Yang, Siwei and Chen, Xiying and Mao, Jianhua and Xie, Shanshan},
  title = {Nephronophthisis: Current clinical spectrum and molecular pathogenesis},
  journal = {The FEBS Journal},
  year = {2026},
  doi = {10.1111/febs.70646}
}
Kostenlos starten →